Market Cap 299.11M
Revenue (ttm) 2.80M
Net Income (ttm) -130.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,653.57%
Debt to Equity Ratio 0.00
Volume 190,200
Avg Vol 298,604
Day's Range N/A - N/A
Shares Out 29.38M
Stochastic %K 64%
Beta 0.66
Analysts Strong Sell
Price Target $34.57

Company Profile

Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company's lead product candidate is Descartes-08, an autologous mRNA chimeric antigen receptor T-cell cell therapy (CAR-T) directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized myasthenia gravis, and systemic lupus erythematosus, as well as rare pediatric disease...

Industry: Biotechnology
Sector: Healthcare
Phone: 301 348 8698
Address:
7495 New Horizon Way, Frederick, United States
maplelakeduckslayer
maplelakeduckslayer Jun. 17 at 2:30 PM
0 · Reply
STACKD0E
STACKD0E Jun. 17 at 2:07 AM
0 · Reply
Amb8675309
Amb8675309 Jun. 15 at 6:16 PM
$RNAC why is it down so much today
1 · Reply
mrtradez
mrtradez Jun. 14 at 10:36 PM
This week runners in our room 🚀 Our scanner called great trades to help users win huge: Supernova one ✨ $INHD +4000% $RNAC +53% $EDHL +313% Chase the smart money, will talk about companies that $SPCX depends on. Subscribe to get the full list. https://whop.com/checkout/plan_jOxwGZl2pPA5x
0 · Reply
topstockalerts
topstockalerts Jun. 12 at 8:01 PM
$RNAC slow grind higher… those can be the best setups
0 · Reply
GoldenEagleTrader
GoldenEagleTrader Jun. 12 at 3:54 PM
$RNAC here comes the push
0 · Reply
abcdzepeda
abcdzepeda Jun. 12 at 3:47 PM
$RNAC we’ve been seeing good volume now for about a week, we could be headed towards an upward trend! 
1 · Reply
lebum_james
lebum_james Jun. 12 at 2:30 PM
$RNAC well that was quick 🤣 GLTA
0 · Reply
ifinitis
ifinitis Jun. 11 at 8:58 PM
$RNAC High Volume last 3 days on up move! Looks Bullish to me!
0 · Reply
ifinitis
ifinitis Jun. 10 at 8:28 PM
$RNAC "Wedbush analyst Martin Fan reiterates Cartesian Therapeutics(RNAC) with a Outperform and maintains $38 price target." per BENZINGA
0 · Reply
Latest News on RNAC
Cartesian Therapeutics Transcript: AGM 2026

Jun 12, 2026, 10:00 AM EDT - 12 days ago

Cartesian Therapeutics Transcript: AGM 2026


Cartesian Therapeutics Quarterly report: Q1 2026

Apr 30, 2026, 7:00 AM EDT - 7 weeks ago

Cartesian Therapeutics Quarterly report: Q1 2026


Cartesian Therapeutics Earnings release: Q1 2026

Apr 30, 2026, 7:00 AM EDT - 7 weeks ago

Cartesian Therapeutics Earnings release: Q1 2026


Cartesian Therapeutics management to meet with BTIG

2026-04-28T14:36:10.000Z - 2 months ago

Cartesian Therapeutics management to meet with BTIG


Cartesian Therapeutics Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Cartesian Therapeutics Proxy statement: Proxy filing


Cartesian Therapeutics Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Cartesian Therapeutics Proxy statement: Proxy filing


Cartesian Therapeutics Earnings release: Q4 2025

Mar 9, 2026, 7:00 AM EDT - 3 months ago

Cartesian Therapeutics Earnings release: Q4 2025


Cartesian Therapeutics Annual report: Q4 2025

Mar 9, 2026, 7:00 AM EDT - 3 months ago

Cartesian Therapeutics Annual report: Q4 2025


Cartesian Therapeutics Slides: Corporate presentation

Mar 5, 2026, 7:00 AM EST - 3 months ago

Cartesian Therapeutics Slides: Corporate presentation


Cartesian Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 7:00 AM EST - 8 months ago

Cartesian Therapeutics Earnings release: Q3 2025


Cartesian Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 7:00 AM EST - 8 months ago

Cartesian Therapeutics Quarterly report: Q3 2025


Cartesian Therapeutics appoints Brunn as Chairman of Board

2025-10-30T11:16:19.000Z - 8 months ago

Cartesian Therapeutics appoints Brunn as Chairman of Board


Cartesian Therapeutics reports Q2 EPS 50c vs. 54c last year

2025-08-07T11:16:41.000Z - 11 months ago

Cartesian Therapeutics reports Q2 EPS 50c vs. 54c last year


Cartesian Therapeutics sees cash runway into mid-2027

2025-08-07T11:16:34.000Z - 11 months ago

Cartesian Therapeutics sees cash runway into mid-2027


Cartesian Therapeutics Earnings release: Q2 2025

Aug 7, 2025, 7:00 AM EDT - 11 months ago

Cartesian Therapeutics Earnings release: Q2 2025


Cartesian Therapeutics Quarterly report: Q2 2025

Aug 7, 2025, 7:00 AM EDT - 11 months ago

Cartesian Therapeutics Quarterly report: Q2 2025


Cartesian Therapeutics Earnings release: Q1 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

Cartesian Therapeutics Earnings release: Q1 2025


Cartesian Therapeutics Quarterly report: Q1 2025

May 8, 2025, 7:00 AM EDT - 1 year ago

Cartesian Therapeutics Quarterly report: Q1 2025


Cartesian Therapeutics Slides: Corporate Presentation

May 7, 2025, 7:00 AM EDT - 1 year ago

Cartesian Therapeutics Slides: Corporate Presentation


Cartesian Therapeutics Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Cartesian Therapeutics Proxy statement: Proxy Filing


Cartesian Therapeutics Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Cartesian Therapeutics Proxy statement: Proxy Filing


Cartesian Therapeutics Earnings release: Q4 2024

Mar 13, 2025, 7:00 AM EDT - 1 year ago

Cartesian Therapeutics Earnings release: Q4 2024


Cartesian Therapeutics Annual report: Q4 2024

Mar 13, 2025, 7:00 AM EDT - 1 year ago

Cartesian Therapeutics Annual report: Q4 2024


Cartesian Therapeutics Slides: Investor Presentation

Mar 3, 2025, 7:00 AM EST - 1 year ago

Cartesian Therapeutics Slides: Investor Presentation


Cartesian Therapeutics Earnings release: Q3 2024

Nov 7, 2024, 7:00 AM EST - 1 year ago

Cartesian Therapeutics Earnings release: Q3 2024


Cartesian Therapeutics Quarterly report: Q3 2024

Nov 7, 2024, 7:00 AM EST - 1 year ago

Cartesian Therapeutics Quarterly report: Q3 2024


Cartesian Therapeutics Proxy statement: Proxy Filing

Aug 16, 2024, 8:00 AM EDT - 2 years ago

Cartesian Therapeutics Proxy statement: Proxy Filing


Cartesian Therapeutics Quarterly report: Q2 2024

Aug 8, 2024, 7:15 AM EDT - 2 years ago

Cartesian Therapeutics Quarterly report: Q2 2024


Cartesian Therapeutics Earnings release: Q2 2024

Aug 8, 2024, 7:15 AM EDT - 2 years ago

Cartesian Therapeutics Earnings release: Q2 2024


Cartesian Therapeutics Proxy statement: Proxy Filing

Aug 2, 2024, 8:00 AM EDT - 2 years ago

Cartesian Therapeutics Proxy statement: Proxy Filing


Cartesian Therapeutics Earnings release: Q1 2024

May 8, 2024, 7:00 AM EDT - 2 years ago

Cartesian Therapeutics Earnings release: Q1 2024


Cartesian Therapeutics Quarterly report: Q1 2024

May 8, 2024, 7:00 AM EDT - 2 years ago

Cartesian Therapeutics Quarterly report: Q1 2024


Cartesian Therapeutics Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Cartesian Therapeutics Proxy statement: Proxy Filing


Cartesian Therapeutics Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Cartesian Therapeutics Proxy statement: Proxy Filing


Cartesian Therapeutics Annual report: Q4 2023

Mar 7, 2024, 6:00 AM EST - 2 years ago

Cartesian Therapeutics Annual report: Q4 2023


Cartesian Therapeutics Earnings release: Q4 2023

Mar 7, 2024, 6:00 AM EST - 2 years ago

Cartesian Therapeutics Earnings release: Q4 2023


maplelakeduckslayer
maplelakeduckslayer Jun. 17 at 2:30 PM
0 · Reply
STACKD0E
STACKD0E Jun. 17 at 2:07 AM
0 · Reply
Amb8675309
Amb8675309 Jun. 15 at 6:16 PM
$RNAC why is it down so much today
1 · Reply
mrtradez
mrtradez Jun. 14 at 10:36 PM
This week runners in our room 🚀 Our scanner called great trades to help users win huge: Supernova one ✨ $INHD +4000% $RNAC +53% $EDHL +313% Chase the smart money, will talk about companies that $SPCX depends on. Subscribe to get the full list. https://whop.com/checkout/plan_jOxwGZl2pPA5x
0 · Reply
topstockalerts
topstockalerts Jun. 12 at 8:01 PM
$RNAC slow grind higher… those can be the best setups
0 · Reply
GoldenEagleTrader
GoldenEagleTrader Jun. 12 at 3:54 PM
$RNAC here comes the push
0 · Reply
abcdzepeda
abcdzepeda Jun. 12 at 3:47 PM
$RNAC we’ve been seeing good volume now for about a week, we could be headed towards an upward trend! 
1 · Reply
lebum_james
lebum_james Jun. 12 at 2:30 PM
$RNAC well that was quick 🤣 GLTA
0 · Reply
ifinitis
ifinitis Jun. 11 at 8:58 PM
$RNAC High Volume last 3 days on up move! Looks Bullish to me!
0 · Reply
ifinitis
ifinitis Jun. 10 at 8:28 PM
$RNAC "Wedbush analyst Martin Fan reiterates Cartesian Therapeutics(RNAC) with a Outperform and maintains $38 price target." per BENZINGA
0 · Reply
Quantumup
Quantumup Jun. 10 at 3:51 PM
Stifel on $DNTH (Buy; $120) said: $SNY announced this morning that they are discontinuing the MOBILIZE Ph3 of Riliprubart in CIDP patients refractory to IVIg. JNJ ARGX IMVT - ROIV $RNAC KYTX VRTX AZN here's what Stifel went on to say: https://x.com/Quantumup1/status/2064736580997177623?s=20
0 · Reply
ghcb1981
ghcb1981 Jun. 10 at 11:32 AM
$RNAC lets go!!!
0 · Reply
Orlandotrader
Orlandotrader Jun. 9 at 6:59 PM
$RNAC Dump this pump
0 · Reply
topstockalerts
topstockalerts Jun. 9 at 5:45 PM
$RNAC this is starting to look like a trend, not just a bounce
0 · Reply
paid2win
paid2win Jun. 9 at 4:48 PM
$RNAC Cartesian Therapeutics Price Target Maintained With a $44.00/Share by BTIG Jun 9, 2026, 11:44 GMT-5 RNAC +17.41%
0 · Reply
paid2win
paid2win Jun. 9 at 4:41 PM
0 · Reply
paid2win
paid2win Jun. 9 at 4:29 PM
$RNAC Time to Raise the Target
0 · Reply
topstockalerts
topstockalerts Jun. 9 at 4:24 PM
$RNAC buyers are making their presence felt.
0 · Reply
paid2win
paid2win Jun. 9 at 4:16 PM
$RNAC Wedbush Reiterates Outperform Rating for Cartesian Therapeutics (NASDAQ:RNAC) Wedbush restated an "outperform" rating and set a $38.00 price objective on shares of Cartesian Therapeutics in a research report on Friday...
0 · Reply
TreDogg
TreDogg Jun. 9 at 3:12 PM
$RNAC watching the move at $7.00
0 · Reply
lebum_james
lebum_james Jun. 9 at 3:07 PM
$RNAC good result, but noting that this just adds to how much of a pivotal year 2027 will be. annoyingly the gains arent holding up as well today, but i do believe it'll return to the 8-9s soon
0 · Reply
paid2win
paid2win Jun. 9 at 1:55 PM
$RNAC About to cross the VWAP. Margin call time for the shorts.
0 · Reply